Latest Period
Q2 2026
Security Snapshot
Envoy Medical, Inc. - Class A Common Stock (COCH) Institutional Ownership
CUSIP: 29415V109
13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026
Institutions Reporting
32
Shares (Excl. Options)
17,724,152
Price
$0.79
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock
- Symbol
- COCH on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 17,724,152
- Total 13F value
- $13,916,005
- Portfolio coverage rank
- 0%
- Share change
- +450,278
- Value change
- +$375,194
- Number of holders
- 32
- Shares outstanding
- 81,261,337
- SEC-reported price per share
- $0.75
- Insider filing price
- $0.75
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COCH - Envoy Medical, Inc. - Class A Common Stock is tracked under CUSIP 29415V109.
- 32 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 33 to 32 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $11,499,787 to $13,916,005.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 32 institutions filings for Q2 2026.
Security key
29415V109
Latest holder period
Q2 2026
13F holders
32
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
COCH full holder history
Envoy Medical, Inc. SEC filings
Envoy Medical, Inc. company facts
Envoy Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29415V109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
COCH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TAYLOR GLEN A | 85% | +92% | $47,547,634 | +$37,432,500 | 68,909,614 | +370% | Glen A. Taylor | 12 Feb 2026 |
| Anzu SPAC GP I LLC | 11% | $3,806,377 | 2,718,841 | Anzu SPAC GP I LLC | 29 Sep 2023 | |||
| Ayrton Capital LLC | 7.9% | $1,695,994 | 2,457,963 | Ayrton Capital LLC | 31 Dec 2025 |
As of 30 Jun 2026, 32 institutional investors reported holding 17,724,152 shares of Envoy Medical, Inc. - Class A Common Stock (COCH). This represents 22% of the company’s total 81,261,337 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
22%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.4% | 7,650,000 | 0% | 0.36% | $5,958,968 |
| Bleichroeder LP | 7.7% | 6,250,000 | 0% | 0.89% | $4,950,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1% | 880,214 | -0.17% | 0% | $697,129 |
| DSG Capital Advisors, LLC | 0.77% | 625,000 | 0% | 0.07% | $474,188 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.67% | 541,729 | +3.8% | 0% | $429,073 |
| Focus Partners Wealth | 0.52% | 425,310 | +100% | 0% | $336,846 |
| VANGUARD FIDUCIARY TRUST CO | 0.37% | 296,679 | +0.66% | 0% | $234,970 |
| UBS Group AG | 0.23% | 190,838 | +171% | 0% | $151,144 |
| Arcus Capital Partners, LLC | 0.23% | 187,573 | 0% | 0.06% | $148,558 |
| ExodusPoint Capital Management, LP | 0.22% | 182,354 | 0% | $144,424 | |
| NORTHERN TRUST CORP | 0.13% | 109,466 | -1.4% | 0% | $86,697 |
| MORGAN STANLEY | 0.11% | 90,921 | +23% | 0% | $72,010 |
| CIBC Bancorp USA Inc. | 0.1% | 77,887 | 0% | 0% | $61,687 |
| LPL Financial LLC | 0.06% | 48,401 | +70% | 0% | $38,334 |
| JANE STREET GROUP, LLC | 0.04% | 31,223 | 0% | $24,729 | |
| Meteora Capital, LLC | 0.03% | 28,051 | 0% | 0% | $22,216 |
| STATE STREET CORP | 0.03% | 23,872 | 0% | 0% | $18,907 |
| XTX Topco Ltd | 0.02% | 17,146 | 0% | $13,580 | |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 0.01% | 12,000 | 0% | 0.01% | $9,024 |
| BlueStem Wealth Partners, LLC | 0.01% | 10,454 | 0% | 0% | $8,280 |
| Ballew Advisors, Inc | 0.01% | 10,121 | 0% | 0% | $7,611 |
| Spire Wealth Management | 0.01% | 10,025 | 0% | $7,920 | |
| BlackRock, Inc. | 0.01% | 5,309 | -89% | 0% | $4,205 |
| WOLFF WIESE MAGANA LLC | 0% | 4,000 | 0% | $3,168 | |
| Vanguard Global Advisers, LLC | 0% | 3,788 | 0% | 0% | $3,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 17,724,152 | $13,916,005 | +$375,194 | $0.79 | 32 |
| 2026 Q1 | 17,290,374 | $11,499,787 | +$10,009,654 | $0.67 | 33 |
| 2025 Q4 | 1,486,837 | $982,984 | -$542,227 | $0.66 | 26 |
| 2025 Q3 | 2,123,532 | $1,649,025 | -$138,312 | $0.78 | 28 |
| 2025 Q2 | 2,306,452 | $3,275,197 | +$4,340 | $1.42 | 22 |
| 2025 Q1 | 2,303,397 | $2,998,325 | +$429,096 | $1.30 | 22 |
| 2024 Q4 | 2,015,076 | $2,945,656 | +$1,123,694 | $1.43 | 24 |
| 2024 Q3 | 1,032,950 | $3,330,106 | -$247,608 | $3.25 | 18 |
| 2024 Q2 | 1,162,015 | $2,742,612 | -$97,854 | $2.36 | 20 |
| 2024 Q1 | 1,173,098 | $4,593,072 | -$721,402 | $3.92 | 16 |
| 2023 Q4 | 1,646,603 | $3,013,128 | +$3,013,128 | $1.81 | 9 |